₹417.50
+₹0.30 (+0.07%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹67,567 Cr
P/E
161.95
ROE
1.14%
ROCE
3.64%
About Biocon Ltd
Biocon is engaged in the manufacture of biotechnology products and research services. The Company
Founded
1978
CEO
Kiran Mazumdar Shaw
Employees
5,261
HQ
Bangalore, Karnataka
About Biocon Ltd
Biocon is engaged in the manufacture of biotechnology products and research services. The Company
Founded:1978
CEO:Kiran Mazumdar Shaw
Employees:5,261
HQ:Bangalore, Karnataka
Finished Products
1Sale of Products
₹8,800.70Cr2Other Operating Revenues
₹782.30Cr3Others
₹716.40Cr4Sale of Process Waste
₹146.70Cr5Sale of Services
₹30.40Cr6Sale of Traded goods
₹6.40CrRaw Materials
1Raw Material Consumed
₹4,173.40Cr2Purchase & Finished Goods
₹47.40CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹447
52W Low
₹337
Volume2.25M
Avg VolumeN/A
Beta0.67
Dividend Yield0.12%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
161.95x
Valuation
P/B Ratio
1.96x
Valuation
EPS
₹2.56
Valuation
Dividend Yield
0.12%
Valuation
ROE
1.14%
Profitability
ROCE
3.64%
Profitability
Revenue by Segment
Contribution & growth by business line
Biosimilars
+15.7%60.2%
₹10,431.2 Cr
CRDMO
+2.6%21.6%
₹3,738.7 Cr
Generics
+5.0%18.3%
₹3,168.1 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
5.4%
International
94.6%
United States of America47.2%
European Union (including Ireland)27.3%
Rest of the world20.1%
India5.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.45x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.